DE
49
3
HRB
40
3
BIIB
36
8
HD
43
8
NWSA
69
4
ADP
57
2
ZION
49
9
FAST
41
7
MKC
54
3
MPC
28
3
EXR
42
5
SCHW
40
3
CHD
34
7
MSI
52
3
EMR
57
7
CA
19
6
VNO
46
6
GME
61
2
CHRW
53
2
LNC
28
3
DE
49
3
HRB
40
3
BIIB
36
8
HD
43
8
NWSA
69
4
ADP
57
2
ZION
49
9
FAST
41
7
MKC
54
3
MPC
28
3
EXR
42
5
SCHW
40
3
CHD
34
7
MSI
52
3
EMR
57
7
CA
19
6
VNO
46
6
GME
61
2
CHRW
53
2
LNC
28
3
Financhill
Back

Entrada Therapeutics Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
37

TRDA
Entrada Therapeutics

Last Price:
$17.60
Seasonality Move:
-24.47%
Sell
36

SRPT
Sarepta Therapeutics

Last Price:
$118.99
Seasonality Move:
12.18%
Sell
37
Entrada Therapeutics (TRDA) is a Sell

Is Entrada Therapeutics a Buy, Sell or Hold?

  • The current Entrada Therapeutics [TRDA] share price is $17.60. The Score for TRDA is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • TRDA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
36
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $118.97. The Score for SRPT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TRDA Stock Price Chart

What is Entrada Therapeutics's stock price today?

  • The Entrada Therapeutics share price today is $17.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TRDA is experiencing slight buying pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $118.97
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

TRDA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.27 Sell
Relative Strength Index (14 RSI): 41.98 Sell
Chaikin Money Flow: 106552 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.67 - 20.29) Sell
Bollinger Bands (100): (15.2 - 18.88) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 43.28 Sell
Chaikin Money Flow: -1117882 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (112.92 - 130.54) Sell
Bollinger Bands (100): (118.37 - 135.77) Sell

TRDA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.02 Sell
20-day SMA: 19.27 Sell
50-day SMA: 18.48 Sell
200-day SMA: 15.77 Buy
8-day EMA: 18.11 Sell
20-day EMA: 18.7 Sell
50-day EMA: 18.33 Sell
200-day EMA: 16.47 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 123.1 Sell
20-day SMA: 125.31 Sell
50-day SMA: 122.99 Sell
200-day SMA: 129.64 Sell
8-day EMA: 122.43 Sell
20-day EMA: 123.17 Sell
50-day EMA: 123.7 Sell
200-day EMA: 126 Sell

Entrada Therapeutics Earnings Growth & TRDA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.13 per share, and a decrease next year of $4.09 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.79 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.75 per share, and an increase next year of $7.84 per share.

Entrada Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):